throbber
Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`1
`
` UNITED STATES PATENT AND TRADEMARK OFFICE
` ______________
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
` ______________
` ACRUX DDS PTY LTD. & ACRUX LIMITED
` Petitioners,
` v.
`
` KAKEN PHARMACEUTICAL CO., LTD. and
` VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
` Patent Owner and Licensee
` ________________
` Case IPR2017-00190
` U.S. Patent No. 7,214,506
`
` DEPOSITION OF
` JOHN C. STAINES, JR.
`
`Reported by: Donna A. Peterson, Notary Public
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`2
` Expert Deposition of JOHN C. STAINES, JR.,
`taken at the law offices of:
` ROTHWELL, FIGG, ERNST & MANBECK, P.C.
` Suite 800
` 607 14th Street, N.W.
` Washington, D.C. 20005
` Telephone: (202) 783-6040
`
` Pursuant to agreement, before Donna Ann
`Peterson, Notary Public in and for the District of
`Columbia.
`
`1
`
`2
`
`3
`
`4
`
`5 6 7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`3
`
` A P P E A R A N C E S
`
` ON BEHALF OF PETITIONERS:
` LISA N. PHILLIPS, ATTORNEY at LAW
` ROTHWELL, FIGG, ERNST & MANBECK, P.C.
` Suite 800
` 607 14th Street, N.W.
` Washington, D.C. 20005
` Telephone: (202) 783-6040
` lphillips@rfem.com
`
` ON BEHALF OF PATENT OWNER AND LICENSEE:
` JEFFREY M. JACOBSTEIN, ATTORNEY at LAW
` ANTHONY A. HARTMANN, ATTORNEY at LAW
` FINNEGAN, HENDERSON, FARABOW,
` GARRETT & DUNNER, LLP
` Two Seaport Lane
` Boston, Massachusetts 02210-2001
` Telephone: (617) 646-1600
` jeffrey.jacobstein@finnegan.com
` anthony.hartmann@finnegan.com
`
`1
`
`2 3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`4
`
` A P P E A R A N C E S C O N T I N U E D
` ALSO PRESENT BY TELEPHONE:
` TYLER LIU, In-House Counsel for Argentum
`
`1
`
`2
`
`3
`
`4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`5
`
` C O N T E N T S
`EXAMINATION OF JOHN C. STAINES, JR. PAGE
` By Mr. Jacobstein 6
` By Ms. Phillips 175
`
` PREVIOUSLY MARKED EXHIBITS
`ACRUX EXHIBIT NO. PAGE
` 1001 160
` 1526 16
` 1528 20
` 1554 84
` 1582 85
` 1596 112
`
`KAKEN EXHIBIT NO. PAGE
` 2093 148
` 2094 55
` 2095 38
`
`1
`
`2
`
`3
`
`4
`
`5 6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`6
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`09:02:58
`
`09:02:58
`
`09:02:59
`
`09:03:01
`
`09:03:04
`
`09:03:08
`
`09:03:10
`
`09:03:16
`
`09:03:21
`
`09:03:25
`
`09:03:29
`
`09:03:29
`
`09:03:34
`
`09:03:34
`
`09:03:35
`
`09:03:36
`
`09:03:37
`
` P R O C E E D I N G S
`Thereupon,
` JOHN C. STAINES, JR.,
`was called as a witness by counsel for Patent Owner
`and Licensee, and having been duly sworn by the
`Notary Public, was examined and testified as follows:
` MR. JACOBSTEIN: Can I ask for appearances
`before we start?
` MS. PHILLIPS: Lisa Philips, with
`Rothwell, Figg, Ernst & Manbeck, representing
`Petitioners.
` MR. LIU: Tyler Liu, counsel for Argentum.
` MR. JACOBSTEIN: Jeffrey Jacobstein,
`Finnegan, Henderson, Farabow, Garrett & Dunner,
`representing Patent Owner, Kaken Pharmaceuticals, and
`with me is my colleague, Anthony Harston -- Hartmann.
` EXAMINATION BY COUNSEL FOR
` PATENT OWNER AND LICENSEE
`BY MR. JACOBSTEIN:
` Q. Good morning, Mr. Staines.
` A. Good morning.
` Q. Can you state your full name and address
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`7
`
`09:03:39
`
`09:03:39
`
`09:03:42
`
`09:03:43
`
`09:03:44
`
`09:03:51
`
`09:03:52
`
`09:03:55
`
`09:03:56
`
`09:03:59
`
`09:03:59
`
`09:04:00
`
`09:04:02
`
`09:04:05
`
`09:04:06
`
`09:04:06
`
`09:04:08
`
`09:04:10
`
`09:04:12
`
`09:04:14
`
`09:04:17
`
`09:04:19
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`for the record, please?
` A. John Christopher Staines, Jr. Address --
`home address?
` Q. Please.
` A. 14720 Pettit Way, Rockville, Maryland
`20854.
` Q. Have you been deposed before?
` A. One time.
` Q. So you're somewhat familiar with the
`rules.
` A. Yes, yes.
` Q. Let me go over a few things before I get
`started, just to make sure we're all on the same
`page.
` A. Sure.
` Q. I'm going to ask you a series of
`questions. If you don't understand any question I
`ask, or if you need any clarification, please let me
`know. Is that okay?
` A. Yes, that's fine.
` Q. And if you answer a question, I'm going to
`assume that you heard the question and you understood
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`8
`
`09:04:21
`
`09:04:22
`
`09:04:24
`
`09:04:27
`
`09:04:30
`
`09:04:32
`
`09:04:35
`
`09:04:38
`
`09:04:38
`
`09:04:40
`
`09:04:43
`
`09:04:46
`
`09:04:50
`
`09:04:53
`
`09:04:55
`
`09:04:56
`
`09:04:57
`
`09:05:00
`
`09:05:03
`
`09:05:05
`
`09:05:08
`
`09:05:09
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`it. Is that okay?
` A. Yes, I understand.
` Q. We have a court reporter taking down our
`conversation, so it's important that we not talk over
`each other. So please wait for me to finish my
`question before providing your answer, and I will try
`to do the same in return.
` Does that make sense?
` A. It does. I'll do my best.
` Q. During the deposition, counsel for
`Petitioner may object, probably will object at some
`point. When that happens, please wait for the
`objection to finish, and then answer the question,
`unless your counsel instructs you not to do so. Is
`that clear?
` A. Yes.
` Q. If you need a break at any time, just let
`me know. As long as we're not in the middle of back
`and forth between a question and answer, we can
`accommodate you. Does that sounds fair?
` A. Yes.
` Q. Great. You understand you're under oath?
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`9
`
`09:05:11
`
`09:05:12
`
`09:05:15
`
`09:05:17
`
`09:05:19
`
`09:05:20
`
`09:05:24
`
`09:05:26
`
`09:05:27
`
`09:05:32
`
`09:05:34
`
`09:05:34
`
`09:05:35
`
`09:05:37
`
`09:05:38
`
`09:05:44
`
`09:05:48
`
`09:05:50
`
`09:05:52
`
`09:05:54
`
`09:05:55
`
`09:05:57
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
` A. Yes, I do.
` Q. Are there any medications you are taking
`that would prevent you from answering my questions
`accurately and truthfully?
` A. No.
` Q. Are there any other issues that would
`prevent you from answering my questions accurately
`and truthfully?
` A. No.
` Q. You said you've been deposed once before,
`correct?
` A. That's right.
` Q. And was that in a patent case?
` A. No.
` Q. Have you ever served as an expert or
`consultant for Acrux in any previous litigation?
` A. No.
` Q. What about in any context outside of a
`litigation?
` A. No.
` Q. Have you ever served as an expert or
`consultant for Argentum Pharmaceuticals in any
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`10
`
`09:06:00
`
`09:06:02
`
`09:06:03
`
`09:06:06
`
`09:06:07
`
`09:06:09
`
`09:06:14
`
`09:06:15
`
`09:06:25
`
`09:06:29
`
`09:06:36
`
`09:06:38
`
`09:06:41
`
`09:06:42
`
`09:06:45
`
`09:06:46
`
`09:06:49
`
`09:06:51
`
`09:06:54
`
`09:06:58
`
`09:06:59
`
`09:07:01
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`previous litigation?
` A. No.
` Q. What about in any other context outside of
`litigation?
` A. No.
` Q. What did you do to prepare for this
`deposition?
` A. Let's see. I read my report again.
`That's a good place to start. And then I reviewed,
`you know, some of the documents that I cited. And
`then I met with counsel.
` Q. And when you say counsel, do you --
` A. Lisa Phillips.
` Q. Did you meet with any other counsel?
` A. No.
` Q. Did you meet with anyone else in
`preparation for your deposition?
` A. No.
` Q. When you met with Ms. Phillips, when was
`that?
` A. Yesterday.
` Q. And how many hours, approximately, would
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`11
`
`09:07:03
`
`09:07:04
`
`09:07:10
`
`09:07:12
`
`09:07:13
`
`09:07:14
`
`09:07:24
`
`09:07:26
`
`09:07:27
`
`09:07:28
`
`09:07:31
`
`09:07:31
`
`09:07:31
`
`09:45:08
`
`09:45:08
`
`09:08:03
`
`09:08:07
`
`09:08:11
`
`09:08:14
`
`09:08:18
`
`09:08:18
`
`09:08:19
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`you say you met?
` A. All day, so eight hours, I guess.
` Q. Did you speak with anyone on the phone
`during that meeting?
` A. No.
` Q. You said you reviewed some documents. Are
`they documents that are identified in your
`declaration?
` A. Yes.
` Q. Did you review any other documents?
` A. No.
` (Acrux Exhibit No. 1511 was
` previously marked for
` identification.)
`BY MR. JACOBSTEIN:
` Q. I'm handing you -- I'm handing you what's
`been previously marked as Acrux Exhibit 1511. It's
`entitled, Declaration of John C. Staines, Jr., in
`Support of Petitioner's Reply to Patent Owner's
`Response.
` Do you see that?
` A. I do.
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`12
`
`09:08:19
`
`09:08:21
`
`09:08:26
`
`09:08:28
`
`09:08:29
`
`09:08:33
`
`09:08:35
`
`09:08:37
`
`09:08:39
`
`09:08:43
`
`09:08:46
`
`09:08:54
`
`09:08:57
`
`09:09:03
`
`09:09:04
`
`09:09:05
`
`09:09:09
`
`09:09:11
`
`09:09:13
`
`09:09:18
`
`09:09:20
`
`09:09:23
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
` Q. Do you recognize this document?
` A. Yes.
` MS. PHILLIPS: Just before you ask another
`question, I just wanted to note on the record that
`this is the protective -- I'm sorry, the confidential
`version.
`BY MR. JACOBSTEIN:
` Q. Is this the declaration you put together
`for this IPR proceeding?
` A. Yes, it appears to be.
` Q. If you could look at page 100 of 120,
`you'll see a signature there and the date of November
`1st, 2017.
` Is that your signature?
` A. Yes, it is.
` Q. And do you have any corrections or updates
`that you'd like to provide before we go any further
`discussing the declaration?
` A. No.
` Q. Did you prepare the initial draft of your
`declaration, or did you review a draft that was
`already prepared for you by counsel?
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`13
`
`09:09:25
`
`09:09:27
`
`09:09:31
`
`09:09:34
`
`09:09:36
`
`09:09:37
`
`09:09:38
`
`09:09:46
`
`09:09:47
`
`09:09:48
`
`09:09:51
`
`09:09:53
`
`09:09:56
`
`09:09:59
`
`09:10:05
`
`09:10:09
`
`09:10:13
`
`09:10:14
`
`09:10:18
`
`09:10:21
`
`09:10:25
`
`09:10:32
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
` MS. PHILLIPS: Objection, compound.
` THE WITNESS: I'll answer anyway.
` I prepared the draft. I did the draft of
`the report from the beginning.
`BY MR. JACOBSTEIN:
` Q. How were edits made?
` A. Edits were made -- you mean, mechanically,
`how were they made or --
` Q. Let me make that a little more clear.
` So once the initial draft was prepared --
` A. Uh-huh.
` Q. Did you receive any edits from counsel or
`did you make the only changes to the document?
` A. I received suggestions for edits that I
`either accepted or didn't or changed or whatever, so
`there was -- there were edits suggested, yes, from
`counsel.
` Q. And did you consider any documents, other
`than those listed in the declaration, when you
`prepared the declaration?
` A. By -- I've seen other documents that I
`didn't rely upon in searching for documents, and so
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`14
`
`09:10:36
`
`09:10:39
`
`09:10:44
`
`09:10:47
`
`09:10:48
`
`09:10:50
`
`09:10:54
`
`09:10:57
`
`09:10:58
`
`09:11:00
`
`09:11:02
`
`09:11:04
`
`09:11:09
`
`09:11:13
`
`09:11:15
`
`09:11:21
`
`09:11:23
`
`09:11:24
`
`09:11:29
`
`09:11:35
`
`09:11:38
`
`09:11:42
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`in that sense, I may have. But documents that I
`relied on are listed -- all listed here.
` Q. And did you find all of those documents
`yourself?
` MS. PHILLIPS: Objection, vague.
` THE WITNESS: No, I have an assistant that
`assisted me.
`BY MR. JACOBSTEIN:
` Q. And did your -- did counsel provide you
`with any of the documents you cited in the
`declaration?
` A. Provided in the sense -- well, there were
`some documents, yes, that -- that counsel did provide
`me, yes.
` Q. So when you said your assistant helped you
`find documents, how did you generally search for
`them?
` A. So I did a lot of the searching myself.
`There were certain things that I delegated to my
`assistant to look for, because she's better at
`finding certain things than I am. And so, you know,
`there was no particular rhyme or reason, but things
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`15
`
`09:11:44
`
`09:11:48
`
`09:11:52
`
`09:11:55
`
`09:11:59
`
`09:12:11
`
`09:12:17
`
`09:12:17
`
`09:12:20
`
`09:12:21
`
`09:12:22
`
`09:12:24
`
`09:12:24
`
`09:12:29
`
`09:12:30
`
`09:12:31
`
`09:12:35
`
`09:12:36
`
`09:12:38
`
`09:12:47
`
`09:12:48
`
`09:12:52
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`like, you know, 10-K's, things like that that she
`could go find and get things, she would get those
`kind of things.
` Q. Would you take a look at page 10 of your
`declaration, please. Paragraph 10 says, "Jublia is
`an azole anti-fungal agent," do you see that?
` A. I do.
` Q. Can you describe the structure of an azole
`to me?
` MS. PHILLIPS: Objection, outside the
`scope. Answer if you know.
` THE WITNESS: Describe it chemically?
`BY MR. JACOBSTEIN:
` Q. Uh-huh.
` A. No.
` Q. How about the structure of efinaconazole?
` MS. PHILLIPS: Same objection.
` THE WITNESS: And I assume chemically or
`any other way, for that matter, no.
`BY MR. JACOBSTEIN:
` Q. If you take a look at page 12 -- excuse
`me, page 12 and paragraph 12 of your declaration.
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`16
`
`09:12:58
`
`09:12:59
`
`09:13:01
`
`09:13:06
`
`09:13:06
`
`09:13:07
`
`09:13:12
`
`09:13:15
`
`09:13:16
`
`09:13:18
`
`09:13:29
`
`09:13:30
`
`09:13:31
`
`09:13:35
`
`09:13:37
`
`09:13:41
`
`09:13:56
`
`09:13:56
`
`09:13:56
`
`09:14:02
`
`09:14:02
`
`09:14:04
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
` A. Okay.
` Q. It's in a section that's headed
`Alternative Fulfillment Through Philidor, do you see
`that?
` A. Yes.
` Q. And that paragraph 12 says, "Valeant
`secretly controlled Philidor."
` Do you see that?
` A. Yes.
` Q. Then there's a footnote 17 after that
`sentence, do you see that?
` A. I do.
` Q. And footnote 17 cites pages 20 to 23 of
`Exhibit 1526, correct?
` A. Yes.
` Q. We're handing you what's been previously
`marked as Acrux Exhibit 1526.
` (Acrux Exhibit No. 1526 was
` previously marked for
` identification.)
` MS. PHILLIPS: Can we hang on one second?
`This one has tabs. I don't want to be using one that
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`17
`
`09:14:07
`
`09:14:11
`
`09:14:13
`
`09:14:20
`
`09:14:22
`
`09:14:22
`
`09:14:28
`
`09:14:39
`
`09:14:42
`
`09:14:43
`
`09:14:44
`
`09:14:45
`
`09:14:46
`
`09:14:49
`
`09:14:51
`
`09:14:52
`
`09:14:55
`
`09:14:55
`
`09:15:08
`
`09:15:10
`
`09:15:10
`
`09:15:11
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`you have markups on.
` THE WITNESS: But I will.
` MS. PHILLIPS: Here you go. Sorry to have
`interrupted you.
` MR. JACOBSTEIN: Thank you.
`BY MR. JACOBSTEIN:
` Q. Could you turn to page 22 of Exhibit 1526?
` MS. PHILLIPS: Are you referring to the
`added numbers?
` MR. JACOBSTEIN: Yeah.
` MS. PHILLIPS: Okay.
` MR. JACOBSTEIN: So let's set some ground
`rules. We will use the numbers that are added for
`each of these exhibits. They'll be in bold at the
`bottom of each page.
` THE WITNESS: All right, that's good.
`BY MR. JACOBSTEIN:
` Q. So if you could turn to page 22. Do see
`about midway down the page, where it says,
`"Philidor"?
` A. I do.
` Q. Underneath that, it says, "we do not own
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`18
`
`09:15:13
`
`09:15:14
`
`09:15:15
`
`09:15:15
`
`09:15:19
`
`09:15:22
`
`09:15:24
`
`09:15:29
`
`09:15:31
`
`09:15:37
`
`09:15:37
`
`09:15:39
`
`09:15:41
`
`09:15:44
`
`09:15:49
`
`09:15:54
`
`09:15:56
`
`09:15:58
`
`09:15:59
`
`09:16:03
`
`09:16:08
`
`09:16:12
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`or control Philidor."
` Do you see that?
` A. I do.
` Q. So the exhibit you cited in your
`declaration does not actually say that Valeant
`secretly controls Philidor, correct?
` MS. PHILLIPS: Objection, misstates the
`document.
` THE WITNESS: And could you repeat the
`question?
`BY MR. JACOBSTEIN:
` Q. Sure. So your declaration, the paragraph
`12 we were just talking about, said Valeant secretly
`owns Philidor and you cited to Exhibit 1526.
` Does page 22 of Exhibit 1526 say that
`Valeant secretly controlled Philidor?
` MS. PHILLIPS: Objection, mischaracterizes
`the declaration.
` THE WITNESS: It doesn't say that. I
`cited this because, based on what's in this, these
`pages of the document, 22 and 23, I think, I conclude
`from that that they did control and effectively own
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`19
`
`09:16:16
`
`09:16:18
`
`09:16:19
`
`09:16:21
`
`09:16:24
`
`09:16:25
`
`09:16:29
`
`09:16:30
`
`09:16:35
`
`09:16:40
`
`09:16:45
`
`09:16:47
`
`09:16:50
`
`09:16:54
`
`09:16:55
`
`09:16:57
`
`09:17:00
`
`09:17:02
`
`09:17:03
`
`09:17:07
`
`09:17:08
`
`09:17:09
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Philidor.
`BY MR. JACOBSTEIN:
` Q. But the bullet point we're looking at
`right there says we do not own or control Philidor,
`correct?
` A. It says that, that's their -- Valeant's
`interpretation, and what they're trying to
`communicate to investors at the time. At the time.
` Q. Have you reviewed any contracts or other
`formal documents indicating that Valeant controlled
`Philidor?
` A. No, I don't believe any of that's been
`produced that I know -- to my knowledge, and I
`haven't reviewed any.
` Q. So you haven't seen any formal
`confirmation of whether or not Valeant owns or
`controls Philidor, correct?
` MS. PHILLIPS: Objection, vague.
` THE WITNESS: By "formal," do you mean
`contractual, contracts?
`BY MR. JACOBSTEIN:
` Q. Sure. Have you seen any contracts?
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`20
`
`09:17:10
`
`09:17:10
`
`09:17:10
`
`09:45:08
`
`09:45:08
`
`09:17:15
`
`09:17:20
`
`09:17:21
`
`09:17:36
`
`09:17:41
`
`09:17:51
`
`09:17:53
`
`09:17:56
`
`09:17:58
`
`09:18:04
`
`09:18:07
`
`09:18:11
`
`09:18:15
`
`09:18:19
`
`09:18:22
`
`09:18:25
`
`09:18:27
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
` A. Right. No.
` (Acrux Exhibit No. 1528 was
` previously marked for
` identification.)
`BY MR. JACOBSTEIN:
` Q. Put that aside for a second.
` In footnote 17 of your declaration, you
`also cite to Exhibit 1528. I'm handing you a copy of
`what's been previously marked as Acrux's Exhibit
`1528.
` You would agree, wouldn't you, that this
`is a printout from what appears to be a web site
`reporting on an investigation into Valeant?
` A. Yes, I recognize this.
` Q. And it's just a news story, correct?
` A. What do you mean by just a news story?
`It's a news -- it's a -- it's a news article just --
`yes, it's a -- right, a Wall Street Journal article.
` Q. A Wall Street Journal article, okay.
` And does it report any conclusion on the
`investigation into Valeant?
` A. I don't -- I did read it. I don't know
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`21
`
`09:18:38
`
`09:18:41
`
`09:18:45
`
`09:18:49
`
`09:18:51
`
`09:18:54
`
`09:18:57
`
`09:19:03
`
`09:19:06
`
`09:19:13
`
`09:19:17
`
`09:19:18
`
`09:19:30
`
`09:19:31
`
`09:19:44
`
`09:19:46
`
`09:19:49
`
`09:19:52
`
`09:19:56
`
`09:19:57
`
`09:19:59
`
`09:20:03
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`that it does or doesn't, but looking at the
`accusations under the investigation, the fact that is
`under investigation is what I used it for and what
`actions were being investigated.
` Q. So as you sit here today, you're not aware
`of any conclusion, though, from that investigation?
` MS. PHILLIPS: Objection, vague.
` THE WITNESS: Let me just remember what
`the investigation was to make sure I don't -- no, I'm
`not aware of conclusions, if they've come to any or
`where they are in it.
`BY MR. JACOBSTEIN:
` Q. If you could turn to page 13 of your
`declaration. You say that "Valeant's relationship
`with Philidor allowed Valeant to increase sales by
`circumventing or otherwise mitigating the
`effectiveness of pharmacy-level reimbursement
`controls." Do you see that?
` A. That's in paragraph 13?
` Q. It's on page 13.
` A. Oh, sorry.
` MS. PHILLIPS: Don't worry, I did the same
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`22
`
`09:20:06
`
`09:45:08
`
`09:20:06
`
`09:20:07
`
`09:20:10
`
`09:20:14
`
`09:20:17
`
`09:20:21
`
`09:20:22
`
`09:20:32
`
`09:20:34
`
`09:20:34
`
`09:20:39
`
`09:20:39
`
`09:20:40
`
`09:20:43
`
`09:20:48
`
`09:20:54
`
`09:21:02
`
`09:21:04
`
`09:21:08
`
`09:21:12
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`thing.
`BY MR. JACOBSTEIN:
` Q. Sort of midway down on page 13.
` A. Yeah, circumventing -- yes, I see that.
` Q. So you'd agree, wouldn't you, that the
`Philidor sales you're talking about there reflected
`actual prescriptions given to patients, correct?
` MS. PHILLIPS: Objection, vague.
` THE WITNESS: Can you repeat that
`question?
`BY MR. JACOBSTEIN:
` Q. Sure. Are the sales done through
`Philidor --
` A. Uh-huh.
` Q. Sorry, strike that.
` When sales were done through Philidor, was
`a prescription actually given to patients?
` A. I presume they were.
` Q. So when you say that Philidor allowed
`Valeant to increase sales, are you saying that the
`Jublia prescriptions made through Philidor would not
`have occurred without the Philidor relationship?
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`23
`
`09:21:17
`
`09:21:19
`
`09:21:24
`
`09:21:30
`
`09:21:37
`
`09:21:41
`
`09:21:45
`
`09:21:50
`
`09:21:54
`
`09:21:56
`
`09:22:01
`
`09:22:05
`
`09:22:11
`
`09:22:13
`
`09:22:14
`
`09:22:17
`
`09:22:20
`
`09:22:23
`
`09:22:30
`
`09:22:33
`
`09:22:34
`
`09:22:36
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
` A. I'm saying the prescriptions would have
`been fewer.
` Q. How many fewer?
` A. The quantity of prescriptions fewer, I
`don't know. What I do know is the dollar sales
`impact of the fewer number of prescriptions. There
`is some indication of that in, I think it was Kaken
`Exhibit 2094, which did have kind of the -- I refer
`to later in the report a little hump in the
`prescriptions. And so the -- the extent of that hump
`might be reflective of how much the prescriptions
`were -- were inflated by the Philidor business
`practices.
`BY MR. JACOBSTEIN:
` Q. But you're saying that you don't view a
`hundred percent of those sales as ones that should be
`disregarded, correct?
` A. I don't -- I don't have a view on that. I
`haven't opined on whether it should be 100 percent or
`not.
` Q. Do you have an opinion on what specific --
`what specific percentage of Jublia sales would not
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`24
`
`09:22:40
`
`09:22:42
`
`09:22:52
`
`09:22:56
`
`09:23:01
`
`09:23:10
`
`09:23:14
`
`09:23:17
`
`09:23:20
`
`09:23:23
`
`09:23:27
`
`09:23:31
`
`09:23:34
`
`09:23:39
`
`09:23:41
`
`09:23:44
`
`09:23:46
`
`09:23:49
`
`09:23:52
`
`09:23:53
`
`09:23:54
`
`09:23:55
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`have occurred without the Philidor relationship?
` A. The -- I guess ultimately net revenues,
`profits, too, but net revenues are what's important.
`And I think I've indicated in Exhibit 7A, and really
`7B is a better one, what the net sales would have
`been, net sales revenues would have been without the
`Philidor business practices.
` Q. But in terms of a specific percentage,
`you're not sure, correct?
` A. Actually, I can calculate the percent
`decline from the hundred and -- I guess the 106
`million per quarter, the peak, and that declined to
`maybe 33, or what was it, 21 million, that that --
`that might be reflective of it.
` Q. It's reflective, but as you sit here, you
`don't know specifically which Philidor sales would
`not have occurred without Philidor, correct?
` MS. PHILLIPS: Objection, mischaracterizes
`the witness's testimony.
` THE WITNESS: When you say, "which
`Philidor sales," if you mean the particular
`prescriptions that went through particular doctors,
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`25
`
`09:23:58
`
`09:45:08
`
`09:24:04
`
`09:24:07
`
`09:24:10
`
`09:24:12
`
`09:24:14
`
`09:24:22
`
`09:24:24
`
`09:24:28
`
`09:24:31
`
`09:24:34
`
`09:24:36
`
`09:24:47
`
`09:24:49
`
`09:24:52
`
`09:24:57
`
`09:25:01
`
`09:25:04
`
`09:25:05
`
`09:25:10
`
`09:25:15
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`particular channels, that kind of thing, no.
`BY MR. JACOBSTEIN:
` Q. So it's possible that some of the sales
`through Philidor, or even all of them would have
`happened even without Philidor, right?
` MS. PHILLIPS: Objection, compound.
` THE WITNESS: No. Some prescriptions --
`the fact that I can't identify which particular
`prescriptions doesn't mean that I believe that all
`those prescriptions still would have been made. I'm
`saying there would have been far fewer, but I don't
`know which particular ones would be. I can only talk
`about it in aggregate. Let me revise that. I can
`only estimate it in aggregate.
`BY MR. JACOBSTEIN:
` Q. So when you say estimate, you're just
`assuming that a certain percentage of the sales
`through Philidor would not have occurred, correct?
` MS. PHILLIPS: Objection, form.
` THE WITNESS: No, I'm looking at the --
`the evidence that when Philidor was removed, the net
`revenues plummeted, I think is the word I use. And
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`26
`
`09:25:21
`
`09:25:24
`
`09:25:26
`
`09:25:34
`
`09:25:37
`
`09:25:46
`
`09:25:46
`
`09:25:48
`
`09:26:00
`
`09:26:04
`
`09:26:06
`
`09:26:12
`
`09:26:13
`
`09:26:15
`
`09:26:15
`
`09:26:17
`
`09:26:19
`
`09:26:21
`
`09:26:22
`
`09:26:25
`
`09:26:25
`
`09:26:25
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`it's, I think, a fair description of what happened
`after Philidor was removed that there was a
`significant decline in sales. And that is, I
`consider, evidence of the impact Philidor had, the
`Philidor business practices had.
`BY MR. JACOBSTEIN:
` Q. If you could turn to page 17 of your
`declaration. Toward the end of paragraph 15 on that
`page, so page 17. You say that sales made through
`Philidor may have been unprofitable.
` Do you see that? It's right at the end of
`that page.
` A. Sorry, this is page 17?
` MS. PHILLIPS: Page 17 or paragraph?
`BY MR. JACOBSTEIN:
` Q. Page 17, you say a substantial portion may
`have been unprofitable. That's referring to sales
`made through Philidor.
` MS. PHILLIPS: He's referring to the --
`oh.
` THE WITNESS: This 17?
`BY MR. JACOBSTEIN:
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`09:26:27
`
`09:26:29
`
`09:26:31
`
`09:26:32
`
`09:26:34
`
`09:26:34
`
`09:26:37
`
`09:26:40
`
`09:26:41
`
`09:26:43
`
`09:26:46
`
`09:26:48
`
`09:26:51
`
`09:26:53
`
`09:26:59
`
`09:27:01
`
`09:27:05
`
`09:27:11
`
`09:27:16
`
`09:27:21
`
`09:27:25
`
`09:27:28
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`27
` Q. Yeah. So, again, we're going to refer to
`the pages that have been stamped --
` A. Okay, I'm sorry.
` Q. -- at the bottom, not the declaration
`pages.
` A. Okay. And the substantial question --
` Q. It's a little confusing, there's two
`numbers on each page.
` A. Yeah, I see that. And a substantial
`portion may have been unprofitable even on a marginal
`cost basis.
` Q. When you say may have been unprofitable,
`are you speculating there?
` A. No. But I can't say for certain, so I
`would have to consider that speculation. I think
`there's strong suspicion that there would be, because
`they had low profits, not considering the dispensing
`fees. And then also considering that the Walgreens
`later on clearly were negative even for considering
`costs, that there's a -- there's a probability that
`some of these sales may also have been unprofitable,
`but I can't say for certain how many or, you know,
`
`202-220-4158
`
`Henderson Legal Services, Inc.
`www.hendersonlegalservices.com
`
`

`

`Staines, Jr., John C.
`
`Case IPR2017-00190
`
`November 30, 2017
`
`28
`
`09:27:33
`
`09:27:35
`
`09:27:37
`
`09:27:39
`
`09:27:42
`
`09:27:45
`
`09:27:45
`
`09:27:50
`
`09:27:53
`
`09:27:56
`
`09:28:00
`
`09:28:02
`
`09:28:03
`
`09:28:06
`
`09:28:10
`
`09:28:12
`
`09:28:16
`
`09:28:19
`
`09:28:23
`
`09:28:24
`
`09:28:26
`
`09:28:28
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`put a number on it.
` Q. You say probability, but you can't say for
`certain, you haven't seen any information showing
`that Philidor's sales were unprofitable?
` MS. PHILLIPS: Objection, compound,
`mischaracterizes.
` THE WITNESS: No, I've seen no document --

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket